Antisense oligonucleotides (ASOs) are next-generation drugs that can treat disease by blocking the transfer of harmful messages from our genes.
Day: April 21, 2024
New study focuses on the placenta for clues to the development of gestational diabetes
A new study led by the Harvard Pilgrim Health Care Institute has identified that a deficit in the placental expression
Bacteria behind meningitis in babies explained
A milestone study led by University of Queensland researchers has identified the main types of E. coli bacteria that cause
Study reveals how humanity could unite to address global challenges
New research led by the University of Oxford has found that perceptions of globally shared life experiences and globally shared
Coal train pollution increases health risks and disparities
Trains carrying loads of coal bring with them higher rates of asthma, heart disease, hospitalization and death for residents living
Analyzing the progression in retinal thickness could predict cognitive progression in Parkinson’s patients
Although there are still some aspects pending confirmation for its use in the clinical setting, and its resolution needs to
Study opens new avenue for immunotherapy drug development
In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center
Signs of multiple sclerosis show up in blood years before symptoms
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a
